Mesa Laboratories, Inc. (NASDAQ:MLAB – Get Free Report) reached a new 52-week high during trading on Tuesday . The stock traded as high as $113.09 and last traded at $113.51, with a volume of 24604 shares traded. The stock had previously closed at $108.46.
Wall Street Analyst Weigh In
Separately, Weiss Ratings cut shares of Mesa Laboratories from a “sell (d+)” rating to a “sell (d)” rating in a research report on Wednesday, June 3rd. Two analysts have rated the stock with a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, Mesa Laboratories presently has an average rating of “Reduce” and an average price target of $94.00.
Get Our Latest Report on Mesa Laboratories
Mesa Laboratories Trading Up 0.6%
Mesa Laboratories (NASDAQ:MLAB – Get Free Report) last posted its earnings results on Wednesday, May 27th. The medical instruments supplier reported $1.53 EPS for the quarter, missing the consensus estimate of $1.78 by ($0.25). The firm had revenue of $63.72 million during the quarter, compared to the consensus estimate of $65.21 million. Mesa Laboratories had a return on equity of 20.96% and a net margin of 2.69%.During the same quarter last year, the company posted ($1.31) EPS. As a group, equities research analysts anticipate that Mesa Laboratories, Inc. will post 8.74 earnings per share for the current year.
Mesa Laboratories Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Monday, June 15th. Stockholders of record on Friday, May 29th will be issued a $0.16 dividend. The ex-dividend date is Friday, May 29th. This represents a $0.64 annualized dividend and a dividend yield of 0.6%. Mesa Laboratories’s dividend payout ratio (DPR) is 53.33%.
Institutional Inflows and Outflows
Several institutional investors and hedge funds have recently made changes to their positions in the stock. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its holdings in shares of Mesa Laboratories by 4.9% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 3,068 shares of the medical instruments supplier’s stock valued at $364,000 after acquiring an additional 143 shares in the last quarter. American Century Companies Inc. boosted its holdings in shares of Mesa Laboratories by 1.5% in the second quarter. American Century Companies Inc. now owns 13,431 shares of the medical instruments supplier’s stock valued at $1,265,000 after acquiring an additional 194 shares in the last quarter. BNP Paribas Financial Markets boosted its holdings in shares of Mesa Laboratories by 30.9% in the third quarter. BNP Paribas Financial Markets now owns 1,029 shares of the medical instruments supplier’s stock valued at $69,000 after acquiring an additional 243 shares in the last quarter. Deutsche Bank AG boosted its holdings in shares of Mesa Laboratories by 5.9% in the fourth quarter. Deutsche Bank AG now owns 4,440 shares of the medical instruments supplier’s stock valued at $349,000 after acquiring an additional 248 shares in the last quarter. Finally, Northwestern Mutual Wealth Management Co. boosted its holdings in shares of Mesa Laboratories by 5,366.7% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 328 shares of the medical instruments supplier’s stock valued at $26,000 after acquiring an additional 322 shares in the last quarter. 90.60% of the stock is currently owned by institutional investors.
Mesa Laboratories Company Profile
Mesa Laboratories, Inc (NASDAQ: MLAB) is a global provider of instrumentation products designed for critical process monitoring, testing and calibration. Headquartered in Lakewood, Colorado, the company serves a diverse set of end markets including healthcare, pharmaceutical, food and beverage, energy and industrial sectors. With a focus on precision measurement and validation, Mesa Laboratories helps customers ensure regulatory compliance, product safety and operational efficiency across complex manufacturing and sterilization processes.
The company’s product portfolio encompasses biological and chemical indicators for sterilization process validation, digital data loggers and sensors for environmental monitoring, and optical gas analyzers with sample-conditioning solutions for oil, gas and petrochemical applications.
Featured Stories
- Five stocks we like better than Mesa Laboratories
- The Case for Intel Over Pure-Play Quantum Firms
- Apple’s Siri AI Was Finally Announced, So Why Is the Stock Tanking?
- Has Temu-Owner PDD’s Story Changed After Double Miss?
- Tanker Dividends Are Surging, But Income Investors Need to Watch the Cycle
Receive News & Ratings for Mesa Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mesa Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
